CN105079513A - Traditional Chinese medicine composition for treating osteoproliferation - Google Patents
Traditional Chinese medicine composition for treating osteoproliferation Download PDFInfo
- Publication number
- CN105079513A CN105079513A CN201510617807.4A CN201510617807A CN105079513A CN 105079513 A CN105079513 A CN 105079513A CN 201510617807 A CN201510617807 A CN 201510617807A CN 105079513 A CN105079513 A CN 105079513A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating osteoproliferation. The traditional Chinese medicine composition comprises, by weight, 5 parts to 25 parts of yam rhizomes, 10 parts to 30 parts of morinda officinalis, 5 parts to 20 parts of tripterygium wilfordii, 5 parts to 25 parts of botrychium ternatum, 5 parts to 20 parts of rhizoma atractylodis, 5 parts to 25 parts of rhizoma cibotii, 5 parts to 25 parts of kadsura pepper stems, 5 parts to 20 parts of stephania terandra, 5 parts to 25 parts of serissa japonica, 5 parts to 20 parts of cudrania cochinchinensis, 5 parts to 25 parts of loose knots, 5 parts to 20 parts of incised notopterygium, 10 parts to 30 parts of flemingia philippinensis, 5 parts to 25 parts of aristolochia mollissima, 5 parts to 20 parts of gastrodia elata, 5 parts to 25 parts of herba siegesbeckiae, 10 parts to 30 parts of loofah sponges, 5 parts to 25 parts of ampelopsis humulifolia, 5 parts to 25 parts of corydalis decumbens, 5 parts to 20 parts of oenothera biennis, 5 parts to 25 parts of rubus obcordatus and 5 parts to 20 parts of Chinese starjasmine stems. The traditional Chinese medicine composition has the effects of tonifying the liver and the kidney, dispelling wind, eliminating dampness, dispelling arthralgia spasm, relieving pains, clearing and activating the channels and collaterals and promoting blood circulation to remove blood stasis; the traditional Chinese medicine composition is remarkable in osteoproliferation treatment effect, reliable in effect, wide in component medicinal material source, easy and convenient to prepare, mild in medicine property and free of side and toxic effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical product not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is also called hyperplastic osteoarthritis, osteoarthritis (OA), degenerative joint disease, senile arthritis, hypertrophiarthritis, cartilage, the intervertebral disc owing to forming joint, soft tissue degeneration, the degenerations such as ligament, joint margins forms bony spur, and synovial membrane plumpness waits change, and there is osteoclasia, cause insecondary hyperosteogeny, cause joint deformity, when being subject to abnormal load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Hyperosteogeny is common clinical, and frequently-occurring disease is again difficult disease.The method of current treatment hyperosteogeny has two kinds: one, western medicine, the principle of western medicine hyperosteogeny is all antiinflammatory, pain relieving, its common medicine is non-steroid class anti-inflammation analgesic, as ibuprofen, ketoprofen, ibuprofen etc., that is, just temporarily alleviate a little misery, the cause of disease also exists, still as before, maximum drawback is exactly that Long-term taking medicine toxic and side effects is large, impairing the liver kidney in drug withdrawal.Two, operative treatment, operative treatment is that hypertrophy position is removed, painful large, is easy to recurrence, and same because the cause of disease also exists, hypertrophy also can regrowth.
The traditional Chinese medical science thinks that hyperosteogeny belongs to " arthromyodynia " category of the traditional Chinese medical science, also known as " rheumatism involving the bone ".Hyperosteogeny is relevant with wound, strain, obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc.
According to theory of Chinese medical science, for the pathogeny of hyperosteogeny, adopt the method for the treatment of of liver and kidney tonifying, expelling wind and removing dampness, eliminating impediment pain relieving, dredge the meridian passage, promoting blood circulation to remove blood stasis, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome, prior art western medicines in treatment hyperosteogeny is cured the symptoms, not the disease, side effect is large and the deficiency of painful large, the easily recurrence of operative treatment hyperosteogeny, the invention provides a kind of prepare easy, cost is low, evident in efficacy, the Chinese medicine composition for the treatment of hyperosteogeny that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of hyperosteogeny, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 5-25 part, Radix Morindae Officinalis 10-30 part, Radix Tripterygii Wilfordii 5-20 part, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5-25 part, Rhizoma Atractylodis 5-20 part, Rhizoma Cibotii 5-25 part, Caulis Piperis Kadsurae 5-25 part, Radix Stephaniae Tetrandrae 5-20 part, Serissa foetida 5-25 part, Radix Cudraniae 5-20 part, Lignum Pini Nodi 5-25 part, Rhizoma Et Radix Notopterygii 5-20 part, Radix Flemingiae Philippinensis 10-30 part, Herba Aristolochiae Mollissimae 5-25 part, Rhizoma Gastrodiae 5-20 part, Herba Siegesbeckiae 5-25 part, Retinervus Luffae Fructus 10-30 part, heptangle Radix Ampelopsis 5-25 part, Rhizoma Corydalis Decumbentis 5-25 part, Radix Oenotherae erythrosepalae 5-20 part, Cortex schizophragmatis integrifolii radicis 5-25 part, Caulis Trachelospermi 5-20 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of hyperosteogeny, is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 15 parts, Radix Morindae Officinalis 20 parts, Radix Tripterygii Wilfordii 10 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 15 parts, Rhizoma Atractylodis 12 parts, Rhizoma Cibotii 15 parts, Caulis Piperis Kadsurae 15 parts, Radix Stephaniae Tetrandrae 10 parts, Serissa foetida 15 parts, Radix Cudraniae 10 parts, Lignum Pini Nodi 15 parts, Rhizoma Et Radix Notopterygii 12 parts, Radix Flemingiae Philippinensis 20 parts, Herba Aristolochiae Mollissimae 15 parts, 10 parts, Rhizoma Gastrodiae, Herba Siegesbeckiae 15 parts, Retinervus Luffae Fructus 20 parts, heptangle Radix Ampelopsis 15 parts, Rhizoma Corydalis Decumbentis 15 parts, Radix Oenotherae erythrosepalae 10 parts, Cortex schizophragmatis integrifolii radicis 15 parts, Caulis Trachelospermi 10 parts.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Rhizoma Dioscoreae Septemlobae has dampness removing and goes turbid, to dispel the wind blood stasis dispelling effect; Radix Morindae Officinalis has effect of reinforcing the kidney and supporting YANG, bone and muscle strengthening, expelling wind and removing dampness; Radix Tripterygii Wilfordii has expelling wind and removing dampness
,removing obstruction in the collateral to relieve pain
,promoting blood circulation and detumescence
,effect of parasite killing removing toxic substances; Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. has effect of heat-clearing and toxic substances removing, suppressing the hyperactive liver eliminating stagnation, expelling wind for relieving convulsion; Rhizoma Atractylodis have effect that is drying damp and strengthening spleen, expelling wind and cold; Rhizoma Cibotii has the effect in invigorating the liver and kidney, strong spinal column, wind-damp dispelling, sharp joint; Caulis Piperis Kadsurae has effect of wind-damp dispelling, the meridian dredging, stopping numbness pain; Radix Stephaniae Tetrandrae has effect of inducing diuresis to remove edema, wind-expelling pain-stopping; Serissa foetida has dispelling wind to relieve the exterior syndrome
,clearing away heat-damp and promoting diuresis
,effect of relaxing muscles and tendons and activating QI and blood in the collateral; Radix Cudraniae has effect of dispelling wind and removing obstruction in the collateral, removing damp-heat, removing toxic substances and promoting subsidence of swelling; Lignum Pini Nodi has dispeiling pathogenic wind and removing dampness
,channels sootheing and network vessel quickening
,effect of promoting blood circulation and stopping pain; Rhizoma Et Radix Notopterygii has effect of expelling cold and relieving exterior syndrome, expelling wind and dampness, eliminating impediment pain relieving; Radix Flemingiae Philippinensis has effect of expelling wind and removing dampness, bone and muscle strengthening, promoting blood circulation and detoxication; Herba Aristolochiae Mollissimae has expelling wind and removing dampness
,promoting blood circulation to remove obstruction in the collateral
,effect of pain relieving; Rhizoma Gastrodiae has effect of relieving spasm by subduing liver-wind, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral; Herba Siegesbeckiae has effect of expelling wind and removing dampness, dredge the meridian passage, heat-clearing and toxic substances removing; Retinervus Luffae Fructus has effect of dredge the meridian passage, heat-clearing and toxic substances removing, inducing diuresis to remove edema, cooling blood for hemostasis; Heptangle Radix Ampelopsis has promoting blood circulation to remove blood stasis, eliminating inflammation and expelling toxin, granulation promoting long bone, effect except wind damp eliminating; Rhizoma Corydalis Decumbentis has promoting blood circulation to remove obstruction in the collateral
,effect of promoting the circulation of QI to relieve pain; Radix Oenotherae erythrosepalae has effect of bone and muscle strengthening, expelling wind and removing dampness; The relaxing muscles and tendons and activating QI and blood in the collateral that Cortex schizophragmatis integrifolii radicis has, expelling wind and activating blood circulation effect; Caulis Trachelospermi has effect of dispelling wind and removing obstruction in the collateral, removing heat from blood detumescence.The selected medicament composing prescription of the present invention, its drug component, through dialectical compatibility, complements each other using, has synergism, play effect of liver and kidney tonifying, expelling wind and removing dampness, eliminating impediment pain relieving, dredge the meridian passage, promoting blood circulation to remove blood stasis altogether, reach treating both the principal and secondary aspects of a disease to the treatment of hyperosteogeny.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.Various component drug of the present invention adopts decocting soup fumigation and wash method affected part while hot.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property and, do not occur toxic and side effects, effective percentage reaches 92.5%, cure rate 72.5%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 15g, Radix Morindae Officinalis 20g, Radix Tripterygii Wilfordii 10g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 15g, Rhizoma Atractylodis 12g, Rhizoma Cibotii 15g, Caulis Piperis Kadsurae 15g, Radix Stephaniae Tetrandrae 10g, Serissa foetida 15g, Radix Cudraniae 10g, Lignum Pini Nodi 15g, Rhizoma Et Radix Notopterygii 12g, Radix Flemingiae Philippinensis 20g, Herba Aristolochiae Mollissimae 15g, Rhizoma Gastrodiae 10g, Herba Siegesbeckiae 15g, Retinervus Luffae Fructus 20g, heptangle Radix Ampelopsis 15g, Rhizoma Corydalis Decumbentis 15g, Radix Oenotherae erythrosepalae 10g, Cortex schizophragmatis integrifolii radicis 15g, Caulis Trachelospermi 10g.
Embodiment 2
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 10g, Radix Morindae Officinalis 30g, Radix Tripterygii Wilfordii 5g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 20g, Rhizoma Atractylodis 10g, Rhizoma Cibotii 25g, Caulis Piperis Kadsurae 5g, Radix Stephaniae Tetrandrae 15g, Serissa foetida 10g, Radix Cudraniae 20g, Lignum Pini Nodi 5g, Rhizoma Et Radix Notopterygii 15g, Radix Flemingiae Philippinensis 10g, Herba Aristolochiae Mollissimae 20g, Rhizoma Gastrodiae 5g, Herba Siegesbeckiae 25g, Retinervus Luffae Fructus 15g, heptangle Radix Ampelopsis 25g, Rhizoma Corydalis Decumbentis 10g, Radix Oenotherae erythrosepalae 20g, Cortex schizophragmatis integrifolii radicis 10g, Caulis Trachelospermi 15g.
Embodiment 3
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 20g, Radix Morindae Officinalis 15g, Radix Tripterygii Wilfordii 12g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 25g, Rhizoma Atractylodis 5g, Rhizoma Cibotii 10g, Caulis Piperis Kadsurae 20g, Radix Stephaniae Tetrandrae 5g, Serissa foetida 25g, Radix Cudraniae 12g, Lignum Pini Nodi 20g, Rhizoma Et Radix Notopterygii 5g, Radix Flemingiae Philippinensis 30g, Herba Aristolochiae Mollissimae 10g, Rhizoma Gastrodiae 15g, Herba Siegesbeckiae 5g, Retinervus Luffae Fructus 25g, heptangle Radix Ampelopsis 5g, Rhizoma Corydalis Decumbentis 20g, Radix Oenotherae erythrosepalae 5g, Cortex schizophragmatis integrifolii radicis 25g, Caulis Trachelospermi 12g.
Embodiment 4
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 5g, Radix Morindae Officinalis 25g, Radix Tripterygii Wilfordii 15g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 10g, Rhizoma Atractylodis 20g, Rhizoma Cibotii 5g, Caulis Piperis Kadsurae 25g, Radix Stephaniae Tetrandrae 12g, Serissa foetida 20g, Radix Cudraniae 5g, Lignum Pini Nodi 25g, Rhizoma Et Radix Notopterygii 10g, Radix Flemingiae Philippinensis 15g, Herba Aristolochiae Mollissimae 25g, Rhizoma Gastrodiae 12g, Herba Siegesbeckiae 20g, Retinervus Luffae Fructus 10g, heptangle Radix Ampelopsis 20g, Rhizoma Corydalis Decumbentis 5g, Radix Oenotherae erythrosepalae 15g, Cortex schizophragmatis integrifolii radicis 5g, Caulis Trachelospermi 20g.
Embodiment 5
Treat a Chinese medicine composition for hyperosteogeny, its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 25g, Radix Morindae Officinalis 10g, Radix Tripterygii Wilfordii 20g, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5g, Rhizoma Atractylodis 15g, Rhizoma Cibotii 20g, Caulis Piperis Kadsurae 10g, Radix Stephaniae Tetrandrae 20g, Serissa foetida 5g, Radix Cudraniae 15g, Lignum Pini Nodi 10g, Rhizoma Et Radix Notopterygii 20g, Radix Flemingiae Philippinensis 25g, Herba Aristolochiae Mollissimae 5g, Rhizoma Gastrodiae 20g, Herba Siegesbeckiae 10g, Retinervus Luffae Fructus 30g, heptangle Radix Ampelopsis 10g, Rhizoma Corydalis Decumbentis 25g, Radix Oenotherae erythrosepalae 12g, Cortex schizophragmatis integrifolii radicis 20g, Caulis Trachelospermi 5g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 12 centimetres, decocts.Intense fire is adopted to decoct at a simmer, with slow fire boiling 20 ~ 30 minutes after boiling; Second decocts, and adds water and does not have powder about 10 centimetres, decoct.Decoct 15 ~ 20 minutes after water boils.Decoct extracting juice twice, merge.
The present invention, with a kind of Chinese medicine composition for the treatment of hyperosteogeny given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 120 example, man 69 example, female 51 example, 25 ~ 65 years old age.
Two, usage and dosage: during clinical practice, the amounts of components in compositions takes the circumstances into consideration increase and decrease according to the body weight of patient and age.Decoct extracting juice twice, fumigation and wash method affected part half an hour while hot, point early, evening twice, one pair of medicine uses three days, washes rear light and slow exercise joint flexion-extension motion.
Three, criterion of therapeutical effect:
(1) fully recover: patient's pain, swollen, picotement disappearance, joint motion is normal;
(2) effective: patient's pain, swollen, picotement obviously alleviate;
(3) effective: patient's pain, swollen, picotement alleviate to some extent;
(4) invalid; Sings and symptoms is all not improved, and symptom is as front.
Four, therapeutic effect: in this clinical observation case, thermal washing 1-3 month, recovery from illness 87 example, followed up a case by regular visits to and has no recurrence; Effective 14 examples, effective 10 examples, no effect 9.There is not toxic and side effects in treatments period.
Five, model case:
Case 1:
Liu, man, 45 years old.Readme: head neck shoulder and numb limbs and tense tendons, twinge, localized pain, tenderness, night increases the weight of.Be diagnosed as hyperosteogeny.The pharmaceutical treatment prepared with Chinese medicine composition of the present invention 1 month, symptom disappears substantially; Continual cure 1 month, symptom disappears completely.
Case 2:
Normal certain, female, 36 years old.Main suit just feels relieving heel pain on foot, and starting pain is not clearly, does not take notice of, but pain was more and more serious afterwards, and pain like pinprick, so check to hospital, check result is hyperosteogeny.The pharmaceutical treatment prepared with Chinese medicine composition of the present invention 2 months, transference cure, cures completely.
Case 3:
Huang, man, 61 years old.Two knee joint pain, difficulty in walking, X-ray examination knee joint hyperosteogeny.The pharmaceutical treatment prepared with Chinese medicine composition of the present invention 1 month, pain relief; Continual cure 2 months, pain disappears, and cures completely.Follow up a case by regular visits to after 1 year, without recurrence.
Claims (2)
1. treat the Chinese medicine composition of hyperosteogeny for one kind, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 5-25 part, Radix Morindae Officinalis 10-30 part, Radix Tripterygii Wilfordii 5-20 part, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 5-25 part, Rhizoma Atractylodis 5-20 part, Rhizoma Cibotii 5-25 part, Caulis Piperis Kadsurae 5-25 part, Radix Stephaniae Tetrandrae 5-20 part, Serissa foetida 5-25 part, Radix Cudraniae 5-20 part, Lignum Pini Nodi 5-25 part, Rhizoma Et Radix Notopterygii 5-20 part, Radix Flemingiae Philippinensis 10-30 part, Herba Aristolochiae Mollissimae 5-25 part, Rhizoma Gastrodiae 5-20 part, Herba Siegesbeckiae 5-25 part, Retinervus Luffae Fructus 10-30 part, heptangle Radix Ampelopsis 5-25 part, Rhizoma Corydalis Decumbentis 5-25 part, Radix Oenotherae erythrosepalae 5-20 part, Cortex schizophragmatis integrifolii radicis 5-25 part, Caulis Trachelospermi 5-20 part.
2. treat a Chinese medicine composition for hyperosteogeny, it is characterized in that: its raw material of Chinese medicine and weight are: Rhizoma Dioscoreae Septemlobae 15 parts, Radix Morindae Officinalis 20 parts, Radix Tripterygii Wilfordii 10 parts, Botrypus virginianus(L.)Holub[Osmunda virginiana L,Botrychium virginianum(L.) Sw. 15 parts, Rhizoma Atractylodis 12 parts, Rhizoma Cibotii 15 parts, Caulis Piperis Kadsurae 15 parts, Radix Stephaniae Tetrandrae 10 parts, Serissa foetida 15 parts, Radix Cudraniae 10 parts, Lignum Pini Nodi 15 parts, Rhizoma Et Radix Notopterygii 12 parts, Radix Flemingiae Philippinensis 20 parts, Herba Aristolochiae Mollissimae 15 parts, 10 parts, Rhizoma Gastrodiae, Herba Siegesbeckiae 15 parts, Retinervus Luffae Fructus 20 parts, heptangle Radix Ampelopsis 15 parts, Rhizoma Corydalis Decumbentis 15 parts, Radix Oenotherae erythrosepalae 10 parts, Cortex schizophragmatis integrifolii radicis 15 parts, Caulis Trachelospermi 10 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510617807.4A CN105079513A (en) | 2015-09-25 | 2015-09-25 | Traditional Chinese medicine composition for treating osteoproliferation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510617807.4A CN105079513A (en) | 2015-09-25 | 2015-09-25 | Traditional Chinese medicine composition for treating osteoproliferation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105079513A true CN105079513A (en) | 2015-11-25 |
Family
ID=54561433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510617807.4A Pending CN105079513A (en) | 2015-09-25 | 2015-09-25 | Traditional Chinese medicine composition for treating osteoproliferation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105079513A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177775A (en) * | 2016-08-23 | 2016-12-07 | 姚洪超 | A kind of Chinese medicine composition treating hyperosteogeny |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060018536A (en) * | 2004-08-24 | 2006-03-02 | 인성제약(주) | Natural herb extracts having rheumatoid-neuroprotection activity and therapeutic composition |
| CN103191305A (en) * | 2013-02-25 | 2013-07-10 | 孙胜波 | Traditional Chinese medicine composition for treating hyperosteogeny |
-
2015
- 2015-09-25 CN CN201510617807.4A patent/CN105079513A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060018536A (en) * | 2004-08-24 | 2006-03-02 | 인성제약(주) | Natural herb extracts having rheumatoid-neuroprotection activity and therapeutic composition |
| CN103191305A (en) * | 2013-02-25 | 2013-07-10 | 孙胜波 | Traditional Chinese medicine composition for treating hyperosteogeny |
Non-Patent Citations (2)
| Title |
|---|
| 关立峰等: "抑增止痛汤治疗腰椎骨质增生57例", 《中医药学报》 * |
| 龚浩卿: "中西医治疗腰椎骨质增生、椎间盘突出", 《中国乡村医药杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106177775A (en) * | 2016-08-23 | 2016-12-07 | 姚洪超 | A kind of Chinese medicine composition treating hyperosteogeny |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327380B (en) | Chinese medicinal composition for treating knee osteoarthritis | |
| CN103191353B (en) | Traditional Chinese medicine composition for treating tinea pedis and tinea manus | |
| CN103463349B (en) | Traditional Chinese medicine composition for treating acute lumbar sprain | |
| CN103463241B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN105031088A (en) | Foot bathing powder for treating rheumatoid arthritis and preparation method thereof | |
| CN105770734A (en) | Traditional Chinese medicine composition for treating joint sore symptoms of osteoarthritis through external use | |
| CN103211932B (en) | Traditional Chinese medicine composition for treating rheumatism | |
| CN105031213A (en) | Traditional Chine medicine foot bathing powder for treating arthritis and preparation method thereof | |
| CN105343442A (en) | External medicament for treating lubar intervertebral disc protrusion and preparation method thereof | |
| CN104491642A (en) | Foot bath powder for preventing and treating gout | |
| CN104587225A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN105079513A (en) | Traditional Chinese medicine composition for treating osteoproliferation | |
| CN103735763B (en) | One kind treats osteoproliferation and the arthritic Chinese medicine composition of wind-cold and preparation method thereof | |
| CN102784212B (en) | Chinese medicine composition for treating arthralgia-synadrome | |
| CN102349957A (en) | Traditional Chinese medicine composition for treating prurigo | |
| CN105497779A (en) | Traditional Chinese medicine patch for treating acute lumbar sprain | |
| CN103191305A (en) | Traditional Chinese medicine composition for treating hyperosteogeny | |
| CN104758483A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
| CN104997890A (en) | Traditional Chinese medicine preparation for treating fracture | |
| CN104758725A (en) | Traditional Chinese medicine composition for treating articular effusion in knee joints | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN102406704B (en) | Chinese medicinal preparation for treating ankylosing spondylitis | |
| CN105560737A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151125 |
|
| RJ01 | Rejection of invention patent application after publication |